GFAP and Ataxia: TMEV infected, ganciclovir treated, GFAP-transgenic mice (GSTG) showed a significant deterioration of clinical signs including reduced general condition, shaggy fur, waddling gait, and progressive ataxia starting at 71 dpi ([4]; Fig 2A).